MGFA has partnered with Bionews to feature the Myasthenia Gravis News feed on our website, providing the community with research updates, disease management insights, and relevant news. All content is original and produced by Bionews’ editorial staff, and perspectives from patients and caregivers. Information is not meant to replace or provide medical advice.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- MG patients 2 times as likely to have other autoimmune diseases
by Andrea Lobo on April 2, 2026 at 4:45 pmPeople with myasthenia gravis (MG) are twice as likely to be diagnosed with other autoimmune diseases, both before and after an MG diagnosis, than a matched general population, a new study involving patients from Denmark found. This predisposition was particularly strong among patients younger than 50 — meaning those with early-onset MG, known as EOMG The post MG patients 2 times as likely to have other autoimmune diseases appeared first on Myasthenia Gravis News.
- What not to do when living with myasthenia gravis
by Sarah Bendiff on April 2, 2026 at 2:00 pmWhile staying at home and resting are a go-to piece of advice when living with myasthenia gravis (MG), I’ve always loved challenging that idea and trying to live life to the fullest. But what are the real limitations imposed by MG? What’s the list of things to never do that every MG patient should keep The post What not to do when living with myasthenia gravis appeared first on Myasthenia Gravis News.
- Why ‘control’ in MG care may miss what matters most
by Bionews Staff on April 2, 2026 at 11:00 amNizar Souayah, MD, explains why the concept of “control” in MG can be misleading when assessing treatment success. The post Why ‘control’ in MG care may miss what matters most appeared first on Myasthenia Gravis News.
- The progression risks of undertreated MG
by Bionews Staff on April 2, 2026 at 11:00 amNizar Souayah, MD, explains how undertreated MG can progress, impact daily life, and lead to more intensive treatments and side effects. The post The progression risks of undertreated MG appeared first on Myasthenia Gravis News.
- Living with MG means facing impossible choices, but we can survive them
by Mark Harrington on April 1, 2026 at 2:00 pmWith more than 5,000 square feet of space, incredible exterior grounds, a swimming pool, a cabana, and splendorous decorations — especially at Christmastime — it was a house that couldn’t help but impress. Every room glowed with warmth and light. But on that particular morning, it felt enormously empty. I’d been staying there for a The post Living with MG means facing impossible choices, but we can survive them appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.